ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $214,335,000 | +36.8% | 1,245,412 | -0.2% | 0.36% | +56.7% |
Q2 2021 | $156,628,000 | -32.9% | 1,248,131 | -27.5% | 0.23% | -33.4% |
Q1 2021 | $233,484,000 | +6.2% | 1,721,731 | +0.2% | 0.35% | -3.1% |
Q4 2020 | $219,855,000 | +20.2% | 1,718,421 | +5.7% | 0.36% | +5.6% |
Q3 2020 | $182,929,000 | +28.0% | 1,625,606 | +8.3% | 0.34% | -6.4% |
Q2 2020 | $142,963,000 | +15.4% | 1,500,606 | +8.9% | 0.36% | -31.6% |
Q1 2020 | $123,836,000 | +304.1% | 1,377,950 | +138.4% | 0.53% | +364.0% |
Q4 2019 | $30,643,000 | -17.8% | 577,950 | -38.8% | 0.11% | -13.0% |
Q3 2019 | $37,295,000 | -3.8% | 943,950 | 0.0% | 0.13% | -14.9% |
Q2 2019 | $38,778,000 | -1.3% | 943,950 | +11.8% | 0.15% | -21.4% |
Q1 2019 | $39,303,000 | +141.3% | 843,950 | +125.7% | 0.20% | +84.9% |
Q4 2018 | $16,286,000 | +4.5% | 373,950 | +37.3% | 0.11% | +43.2% |
Q3 2018 | $15,585,000 | – | 272,329 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |